注意缺陷多动障碍共病智力障碍的诊治挑战

doi:10.11852/zgetbjzz2024-0567

摘要/Abstract

摘要： 注意缺陷多动障碍(ADHD)是儿童中常见的神经发育障碍,也是智力障碍(ID/DD)人群中最常见的共病之一。共病患者的症状复杂,且功能损害严重,导致诊断困难和治疗效果不佳。对于ADHD共病ID的治疗,需要综合非药物和药物治疗。总体来说,跨专业的综合评估和治疗,结合长期随访和个性化管理,有助于提升共病患者的生活质量和功能。

关键词: 注意缺陷多动障碍, 智力障碍, 共病, 诊治, 儿童

Abstract: Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children and is one of the most common childhood disorders in those with intellectual disability/developmental delay (ID/DD). Patients with this comorbidity present complex symptoms and significant functional impairments, leading to difficulties in diagnosis and suboptimal treatment outcomes. Treatment of ADHD comorbid with ID requires a comprehensive approach that includes both non-pharmacological and pharmacological interventions. Overall, multidisciplinary comprehensive assessment and treatment, combined with long-term follow-up and individualized management, can help improve the quality of life and functionality of patients with this comorbidity.

Key words: attention-deficit/hyperactivity disorder, intellectual disability/developmental delay, comorbidity, diagnosis and treatment, children

中图分类号:

R749.94

章依文. 注意缺陷多动障碍共病智力障碍的诊治挑战[J]. 中国儿童保健杂志, 2024, 32(6): 581-585.

ZHANG Yiwen. Challenge for diagnosis and treatment of attention-deficit/hyperactivity disorder comorbid with intellectual disability/developmental delay[J]. Chinese Journal of Child Health Care, 2024, 32(6): 581-585.

参考文献

[1] Wolraich ML, Hagan JF, Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents[J]. Pediatrics, 2019, 144(4):e20192528.
[2] 金星明,禹东川. 注意缺陷多动障碍标准化门诊建设与规范化管理[M]. 北京:科学出版社, 2019.
[3] 陆林. 沈渔邨精神病学[M]. 6版. 北京:人民卫生出版社, 2018.
[4] Barbaresi WJ, Campbell L, Diekroger EA, et al. Society for developmental and behavioral pediatrics clinical practice guideline for the assessment and treatment of children and adolescents with complex attention-deficit/hyperactivity disorder[J]. J Dev Behav Pediatr, 2020, 41(Suppl 2): 35-37.
[5] Gnanavel S, Sharma P, Kaushal P, et al. Attention deficit hyperactivity disorder and comorbidity: A review of literature[J]. World J Clin Cases, 2019, 7(17): 2420-2426.
[6] Faraone SV, Banaschewski T, Coghill D, et al. The world federation of adhd international consensus statement: 208 evidence-based conclusions about the disorder[J]. Neurosci Biobehav Rev, 2021, 128: 789-818.
[7] Thapar A. Intellectual disability and attention-deficit/hyperactivity disorder: What does the clinical and genetic overlap mean for practice and research?[J]. J Am Acad Child Adolesc Psychiatry, 2017, 56(2): 105-106.
[8] 黎海芪. 实用儿童保健学[M]. 2版. 北京:人民卫生出版社, 2022.
[9] Totsika V, Liew A, Absoud M, et al. Mental health problems in children with intellectual disability[J]. Lancet Child Adolesc Health, 2022, 6(6): 432-444.
[10] 2001年中国0岁～6岁残疾儿童抽样调查主要结果[J]. 中国残疾人, 2004(4): 43.
[11] American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5[M]. 5th ed. Washington DC: American Psychiatric Association, 2013:33, 38-41.
[12] 中华医学会儿科学分会神经学组, 中国医师协会神经内科分会儿童神经疾病专业委员会. 儿童智力障碍或全面发育迟缓病因诊断策略专家共识[J]. 中华儿科杂志, 2018, 56(11): 806-810.
The Subspecialty Group of Neurology, Chinese Society of Pediatrics, Chinese Medical Association;Project Expert Group of Childhood Neuropathy, China Neurologist Association. Experts' consensus on the diagnostic strategies of etiology for intellectual disability or global developmental delay in children[J]. Chin J Pediatr, 2018, 56(11): 806-810. (in Chinese)
[13] Buckley N, Glasson EJ, Chen W, et al. Prevalence estimates of mental health problems in children and adolescents with intellectual disability: A systematic review and meta-analysis[J]. Aust N Z J Psychiatry, 2020,54(10):970-984.
[14] Sun S, Kuja-Halkola R, Faraone SV, et al. Association of psychiatric comorbidity with the risk of premature death among children and adults with attention-deficit/hyperactivity disorder[J]. JAMA Psychiatry, 2019,76(11):1141-1149.
[15] 余珍珠, 张姗红, 钟蕴瑜, 等. 注意缺陷多动障碍儿童的智力特点[J]. 中国心理卫生杂志, 2019, 33(6): 416-419.
Yu ZZ, Zhang SH,Zhong YY, et al. Characteristics of intelligence in children with attention-deficit/hyperactivity disorder[J]. Chinese Mental Health Journal, 2019, 33(6): 416-419.(in Chinese)
[16] 张伟, 方拴锋, 叶蓓, 等. 注意缺陷多动障碍儿童的智力现状及其影响因素[J]. 中国当代儿科杂志, 2023, 25(11): 1175-1179.
Zhang W, Fang SF, Ye B, et al. Intellectual status and factors influencing the intelligence for attention deficit and hyperactivity disorder[J]. Chin J Contemp Pediatr, 2023, 25(11):1175-1179.(in Chinese)
[17] Neece CL, Baker BL, Blacher J, et al. Attention-deficit/hyperactivity disorder among children with and without intellectual disability: An examination across time[J]. J Intellect Disabil Res, 2011, 55(7): 623-635.
[18] Faraone SV, Ghirardi L, Kuja-Halkola R, et al. The familial co-aggregation of attention-deficit/hyperactivity disorder and intellectual disability: A register-based family study[J]. J Am Acad Child Adolesc Psychiatry, 2017, 56(2): 167-174.e1.
[19] Carmeli E, Klein N, Sohn M. The implications of having attention-deficit/hyperactivity disorder in male adolescents with intellectual disability[J]. Int J Adolesc Med Health, 2007, 19(2):209-214.
[20] McClain MB, Hasty Mills AM, Murphy LE. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability[J]. Res Dev Disabil, 2017, 70: 175-184.
[21] Ahuja A, Martin J, Langley K, et al. Intellectual disability in children with attention deficit hyperactivity disorder[J]. J Pediatr, 2013, 163(3): 890-895.e1.
[22] Esbensen A J, Epstein J N, Vincent L B, et al. Comparison of attention deficit hyperactivity disorder in typically developing children and children with Down syndrome[J]. J Dev Behav Pediatr, 2022, 43(1): 1-8.
[23] 陈立. 儿童期复杂注意缺陷多动障碍的评估与治疗[J]. 中国儿童保健杂志, 2023, 31(9): 935-938.
Chen L.Evaluation and treatment of complex attention deficit hyperactivity disorder in childhood[J]. Chin J Child Health Care, 2023, 31(9): 935-938.(in Chinese)
[24] Ferrin M, Moreno-Granados JM, Salcedo-Marin MD, et al. Evaluation of a psychoeducation programme for parents of children and adolescents with ADHD: Immediate and long-term effects using a blind randomized controlled trial[J]. Eur Child Adolesc Psychiatry, 2014, 23(8): 637-647.
[25] Ferrin M, Perez-Ayala V, El-Abd S, et al. A randomized controlled trial evaluating the efficacy of a psychoeducation program for families of children and adolescents with adhd in the United Kingdom: Results after a 6-month follow-up[J]. J Atten Disord, 2020, 24(5): 768-779.
[26] Roux G, Sofronoff K, Sanders M. A randomized controlled trial of group Stepping Stones Triple P: A mixed-disability trial[J]. Fam Process, 2013, 52(3): 411-424.
[27] Leijten P, Gardner F, Landau S, et al. Research review: Harnessing the power of individual participant data in a meta-analysis of the benefits and harms of the Incredible Years parenting program[J]. J Child Psychol Psychiatry, 2018, 59(2): 99-109.
[28] Adams RC, Tapia C, Council on children with disabilities. Early intervention, IDEA Part C services, and the medical home: Collaboration for best practice and best outcomes[J]. Pediatrics, 2013, 132(4): e1073-1088.
[29] Thompson MB, Xu Y, Chen CC, et al. Empowering and educating parents to implement a home intervention: Effects on preschool children's engagement in hands-on constructive play[J]. Behav Sci, 2024, 14(3): 247.
[30] Axelsson AK, Granlund M, Wilder J. Engagement in family activities: A quantitative, comparative study of children with profound intellectual and multiple disabilities and children with typical development[J]. Child Care Health Dev, 2013, 39(4): 523-534.
[31] Van keer I, Van Leeuwen K, Maes B. Exploring family activities and child engagement: A study on children with a significant cognitive and motor developmental delay[J]. J Appl Res Intellect Disabil, 2019, 32(4): 779-791.
[32] Carr EG, Dunlap G, Horner RH, et al. Positive behavior support: Evolution of an applied science[J]. J Posit Behav Interv, 2002, 4(1): 4-16.
[33] Kincaid D. Staying true to our PBS roots in a changing world[J]. J Posit Behav Interv, 2018, 20(1): 15-18.
[34] Beqiraj L, Denne LD, Hastings RP, et al. Positive behavioural support for children and young people with developmental disabilities in special education settings: A systematic review[J]. J Appl Res Intellect Disabil, 2022, 35(3): 719-735.
[35] Froehlich TE. Comparison of medication treatments for preschool children with ADHD: A first step toward addressing a critical gap[J]. JAMA, 2021, 325(20): 2049-2050.
[36] Miller J, Perera B, Shankar R. Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability[J]. Expert Opin Pharmacother, 2020, 21(15): 1897-1913.
[37] Sun CK, Tseng PT, Wu CK, et al. Therapeutic effects of methylphenidate for attention-deficit/hyperactivity disorder in children with borderline intellectual functioning or intellectual disability: A systematic review and meta-analysis[J]. Sci Rep, 2019, 9: 15908.
[38] Aman MG, Buican B, Arnold LE. Methylphenidate treatment in children with borderline IQ and mental retardation: Analysis of three aggregated studies[J]. J Child Adolesc Psychopharmacol, 2003, 13(1): 29-40.
[39] Simonoff E, Taylor E, Baird G, et al. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability[J]. J Child Psychol Psychiatry, 2013, 54(5): 527-535.
[40] Tarrant N, Roy M, Deb S, et al. The effectiveness of methylphenidate in the management of attention deficit hyperactivity disorder (ADHD) in people with intellectual disabilities: A systematic review[J]. Res Dev Disabil, 2018, 83: 217-232.
[41] Fernández-Jaén A, Fernández-Mayoralas DM, Pérez BC, et al. Atomoxetine for attention deficit hyperactivity disorder in mental retardation[J]. Pediatr Neurol, 2010, 43(5): 341-347.
[42] Mazzone L, Reale L, Mannino V, et al. Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder[J]. CNS Drugs, 2011, 25(6): 503-509.
[43] Hinshaw SP, Arnold LE, MTA Cooperative Group. Attention-deficit hyperactivity disorder, multimodal treatment, and longitudinal outcome: Evidence, paradox, and challenge[J]. Wiley Interdiscip Rev Cogn Sci, 2015, 6(1): 39-52.